Method for modifying plant architecture and enhancing plant biomass and/or sucrose yield

ABSTRACT

The present invention relates to methodology and constructs for modifying plant architecture and enhancing plant biomass and/or sucrose yield.

RELATED APPLICATION

This application claims priority of U.S. Provisional Application No.60/863,252, filed Oct. 27, 2006, the disclosure of which is incorporatedby reference in its entirety.

FIELD OF THE INVENTION

The present invention relates to the field of molecular biology and thephenotypic alteration of plant characteristics through the introductionof foreign genes into plant cells, preferably into their genomes. Moreparticularly, the present invention pertains to methods and compositionsfor producing transgenic plants having modified plant architecture andenhanced biomass and/or sucrose yield with respect to non-transgenicplants grown in similar conditions.

BACKGROUND

Sugarcane is one of the most photosynthetic efficient cultivated crops.Sugarcane average annual yields in Brazil, world's largest producer,range from 80 to 120 tons/ha. Yet, the productivity potential of 300tons of biomass per hectare has been suggested. Alexander, THE ENERGYCANE ALTERNATIVE (Elsevier, 1985).

The utilization of biomass has been the subject of strong interestrecently, particularly with respect to the efforts to develop methods toproduce alternate fuels that use non-starch, non-food-related biomass,such as trees, grasses and waste materials, which would expand theavailable resource base for sugars and would lower cost sources. InBrazil, sugarcane mills have developed technologies for large-scalesucrose fermentation for producing fuel ethanol. In the 2006/2007 crop,approximately 18 billion liters of sugarcane-derived ethanol wereproduced. In addition to providing a renewable source of fuel,sugarcane-based fuel provides a means for reducing CO₂ emissions.

Over the centuries, sugarcane was cultivated almost solely as a sourceof sucrose, which accumulates at high concentrations in the steminternodes. The sucrose then is extracted and purified in large millfactories, and is used as a raw material in food industries.

While sugarcane is photosynthetically efficient, the averageproductivity of commercial sugarcane plantations around the world islimited by the highly polyploid nature of the sugarcane genome, whichrenders sugarcane not amenable to most of the breeding techniquesdeveloped for diploid species. Because traditional breeding programshave provided limited success in producing high-yielding plants,cultivated sugarcane varieties are clones derived from interspecificcrosses between Saccharum officinarum with its relatives, most often S.spontaneum but also S. sinense or S. barberi, whose progenies werebackcrossed to S. officinarum. On the other hand, the emergence ofmolecular genetics approaches to manipulating plant genomes has offeredresearchers a means for developing crops with improved properties ortraits, through introduction and expression of recombinant nucleic acidmolecules in plants.

SUMMARY OF THE INVENTION

In one aspect, the invention provides a transgenic plant belonging to afamily selected from the group consisting of Poaceae, Cucurbitaceae,Cruciferaceae, Solanaceae, Leguminosae, and Apocynaceae plant family,wherein the plant contains an endogenous Ss2-ODD1 DNA sequence theexpression of which is reduced compared to a wild-type control plant. Infurther embodiment, the plant belongs to Poacea family. In even furtherembodiments, the transgenic plant is sugarcane, sorghum, corn andMiscanthus. In another embodiment, the expression of Ss2-ODD1 DNAsequence is reduced by antisense suppression, sense co-suppression, RNAinterference, or enzymatic RNA.

In another aspect, the invention provides a method for producingsucrose, comprising: (a) providing a transgenic plant having suppressedSs2-ODD1 protein levels; and (b) obtaining sucrose from said plant. Inone embodiment, the plant is sugarcane or sorghum.

In another aspect, the invention provides a method for producingbiomass, comprising: (a) providing a transgenic plant having suppressedSs2-ODD1 protein levels; and (b) obtaining biomass from said plant. Inone embodiment, the plant is sugarcane or sorghum.

In another aspect, the invention provides a method for enhancing sucroseyield in a plant, comprising: suppressing Ss2-ODD1 protein levels insaid plant. In one embodiment, the plant is sugarcane or sorghum.

In another aspect, the invention provides a method for enhancing biomassin a plant yield, comprising: suppressing Ss2-ODD1 protein levels insaid plant. In one embodiment, the plant is sugarcane or sorghum.

In another aspect, the invention provides a nucleic acid constructcomprising an Ss2-ODD1 sequence. In further embodiment, the inventionprovides a transgenic plant or cell comprising the nucleic acidconstruct comprising an Ss2-ODD1 sequence.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows conservation of functional amino acid residues in Ss2-ODD1,its close homologues from Oryza sativa, Sorghum bicolor and Zea mays andplant ferrous iron-dependent dioxygenases. Numbering of residues wasbased on the isopenicillin N synthase (IPNS) protein from Streptomycesjumonjinensis. The alignment shows conserved residues (underlined)including the iron binding motif His-X-Asp(53-57)X-His (shaded) that iscommon to non-heme Fe(II) dependent dioxygenases (Kreisberg-Zakarin etal., Antonie Van Leeuwenhoek 75: 33-39, 1999). These conserved residuesare presumed to be necessary for iron binding in the active site(Borovok et al., Biochemistry 35: 1981-1987, 1996). Ss, Saccharumspecies; Sb, Sorghum bicolor; Zm, Zea mays; ORYSA, Oryza sativa; ARATH,Arabidopsis thaliana; CUCMA, Cucurbita maxima; STRJU, Streptomycesjumonjinensis; PETHY, Petunia hybrida; GARPE, garden petunia; 2-ODD1,2-oxoacid-dependent dioxygenase; GA2, Gibberellin 2β-Hydroxylases; GA20,Gibberellin 20-Oxidases; GA3, Gibberellin3β-Hydroxylases; GA7,Gibberellin 7-Oxidases; A2, A2 gene; LDOX, leucoanthocyanidindioxygenase; FLS, flavonol synthase; FL3H, Flavanone 3β-Hydroxylase;2A6, 2A6 gene.

FIG. 2 shows phylogenetic analysis of higher plant 2-ODDs. Amino acidsequences of higher plant representatives of major 2-ODDS types werealigned with the Clustal algorithm using the BLOSUM matrix. Phylogeneticreconstructions were obtained in MEGA version 3.1 (Kumar et al., BriefBioinform. 5: 150-163, 2004) by the Neighbor-Joining method (NJ) withrobustness of nodes of the phylogenetic trees assessed by bootstrapping(1,000 resamplings). Bootstrap values larger than 50 are shown. GenBankgi or TIGR TC numbers are provided following sequence names. Ss2-ODD1 isboxed. Proteins with corresponding characterized gibberellic acidoxidase mutants of Arabidopsis thaliana (GA5, GA4), Oryza sativa (D18,SEMIDWARF1), and Pisum sativum (SLENDER) are indicated. Species andprotein names are abbreviated as follows: At, Arabidopsis thaliana; Cm,Cucurbita maxima; Cr, Capsella rubella; Cro, Catharanthus roseus; Hv,Hordeum vulgare; Hn, Hyoscyamus niger; Le, Lycopersicum esculentum; Mm,Marah macrocarpus; Ms, Medicago sativa; Mt, Medicago truncatula; Nt;Nicotiana tabacum; Os, Oryza sativa; Ps, Pisum sativum; Pt,Petunia×hybrida; St, Solanum tuberosum; Sb, Sorghum bicolor; Ss,Saccharum species; Zm, Zea mays. A2, protein encoded by the A2 locusthat affects anthocyanin biosynthesis; ACCO,1-aminocyclopropane-1-carboxylate oxidase; ANS, anthocyanidin synthase;CFI, chalcone-flavonone isomerase; DV4H, desacetoxyvindoline4-hydroxylase; E8, 1-aminocyclopropane-1-carboxylate oxidase homolog(protein E8); F3H, flavonone-3-hydroxylase; FLS, flavonol synthase;GAoxi, gibberellic acid oxidase; H6H, hyoscyamine 6-dioxygenase; IDS2,iron deficiency specific-2; LDOX, leucoanthocyanidin dioxygenase; P4H,prolyl 4-hydroxylase; SRG1, encoded transcript expressed ingrowth-arrested Arabidopsis thaliana cells.

FIG. 3 shows schematic representation of UBI-1::Ss2-ODD1as::NOS andUBI-1::Bar::NOS cassettes. Endonucleases (EarI and HindIII) used forreleasing cassettes from original cloning vectors are shown.

FIG. 4 shows height of selected UBI-1::Ss2-ODD1as::NOS events andnon-transgenic control cultivar RB835486. Height of two stems wasmeasured for each sample (n=12) after removal of the stalk apicalsections. Double asterisks indicate events significantly different fromthe cultivar RB835486 non-transgenic control (C) as determined by theDunnett's method at the 99% confidence level. Error bars indicatestandard deviation of the mean.

FIG. 5 shows internode number of selected UBI-1::Ss2-ODD1as::NOS eventsand non-transgenic control cultivar RB835486. Internode number of twostalks was determined for each sample (n=12) after removal of the apicalsection. Double asterisks indicate events significantly different fromthe cultivar RB835486 non-transgenic control (C) as determined by theDunnett's method at the 99% confidence level. Error bars indicatestandard deviation of the mean.

FIG. 6 shows average internode length of selected UBI-1::Ss2-ODD1as::NOSevents and non-transgenic control cultivar RB835486. Length of allinternodes of two stalks was measured for each sample (n=12) afterremoval of the apical part. Double asterisks indicate eventssignificantly different from the cultivar RB835486 non-transgeniccontrol (C) as determined by the Dunnett's method at the 99% confidencelevel. Error bars indicate standard deviation of the mean.

FIG. 7 shows average internode diameter of selectedUBI-1::Ss2-ODD1as::NOS events and non-transgenic control cultivarRB835486. Internode diameter of two stalks was measured for each sample(n=12) after removal of the apical section. Double asterisks indicateevents significantly different from the cultivar RB835486 non-transgeniccontrol (C) as determined by the Dunnett's method at the 99% confidencelevel. Error bars indicate standard deviation of the mean.

FIG. 8 shows stalk fresh weight of selected UBI-1::Ss2-ODD1as::NOSevents and non-transgenic control cultivar RB835486. Fresh weight of twocombined stalks was measured for each sample (n=12) after removal of theapical section. Double asterisks indicate events significantly differentfrom the cultivar RB835486 non-transgenic control (C) as determined bythe Dunnett's method at the 99% confidence level. Error bars indicatestandard deviation of the mean.

FIG. 9 shows juice volume of selected UBI-1::Ss2-ODD1as::NOS events andnon-transgenic control cultivar RB835486. Juice volume extracted fromtwo combined stalks was measured for sample (n=12) after removal of theapical section. Double asterisks indicate events significantly differentfrom the cultivar RB835486 non-transgenic control (C) as determined bythe Dunnett's method at the 99% confidence level. Error bars indicatestandard deviation of the mean.

FIG. 10 shows POL of selected UBI-1::Ss2-ODD1as::NOS events andnon-transgenic control cultivar RB835486. POL of juice extracted fromtwo combined stalks was measured for each sample (n=12) after removal ofthe apical section. Double asterisks indicate events significantlydifferent from the cultivar RB835486 non-transgenic control (C) asdetermined by the Dunnett's method at the 99% confidence level. Errorbars indicate standard deviation of the mean.

FIG. 11 shows sucrose yield of selected UBI-1::Ss2-ODD1as::NOS eventsand non-transgenic control cultivar RB835486. Sucrose yield wascalculated as a product of total juice volume and its sucroseconcentration from two combined stalks for each sample (n=12) afterremoval of the apical section. Double asterisks indicate eventssignificantly different from the cultivar RB835486 non-transgeniccontrol (C) as determined by the Dunnett's method at the 99% confidencelevel. Error bars indicate standard deviation of the mean.

FIG. 12 shows bagasse fresh weight of selected UBI-1::Ss2-ODD1as::NOSevents and non-transgenic control cultivar RB835486. Bagasse freshweight of two combined stalks was measured for each sample (n=12) afterremoval of the apical section. Double asterisks indicate eventssignificantly different from the cultivar RB835486 non-transgeniccontrol (C) as determined by the Dunnett's method at the 99% confidencelevel. Error bars indicate standard deviation of the mean.

FIG. 13 shows expression of Ss2-ODD1 transcripts in wild-type sugarcaneorgans measured by quantitative reverse transcription-polymerase chainreaction (qRT-PCR). Quantitative reverse transcription-polymerase chainreaction (qRT-PCR) was performed using RNA isolated from differentorgans of wild-type sugarcane plants (cultivar RB835486). Abundance ofSs2-ODD1 transcripts relative to those of ACTIN (ACT) are expressed asΔCT values. Bars indicate mean values from three independent replicates.Error bars indicate standard deviation of the mean.

FIG. 14 shows Ss2-ODD1 protein levels in the leaf +4 of selectedUBI-1::Ss2-ODD1as::NOS events and wild-type sugarcane cultivar RB835486controls. Extracts were prepared from blades of leaf +4 harvested fromcultivar RB835486 wild-type plants (C) and events 09, 14 and 21. Leafprotein extracts (50 μg) along with 0.5 ng of recombinant Ss2-ODD1(rSs2-ODD1) were separated by SDS-PAGE. Immunoblotting was performedwith Ss2-ODD1 affinity-purified antibodies (upper panel). Arrowheadindicates Ss2-ODD1 protein. Asterisk indicates a non-specificcross-reacting polypeptide in leaf extracts shown as loading control.Molecular weights are shown at the right (MW) expressed in kDa. The gelstained with Coomassie Blue after transfer is shown as a loading control(bottom panel).

DETAILED DESCRIPTION OF THE INVENTION

The present invention relates to methodology and constructs formanipulating a dioxygenase enzyme in planta, thereby modifying plantarchitecture and enhancing plant biomass and/or sucrose yield.Dioxygenases are iron-containing, non-heme enzymes that are involved inthe biosynthesis of many compounds, including penicillin, cephalosporin,cephamycin, clavam, carnitine and collagen biosynthesis (Prescott andLloyd, Nat. Prod. Rep., 17: 367-383, 2000). Also, some dioxygenases havelong been described to oxidize several amino acids residues in variousprotein targets to facilitate protein folding. Modifications in aminoacid oxidation permit regulatory and structural mechanisms (Ozer andBruick, Nat. Chem. Biol., 3: 144-153, 2007). In plants particularly,various dioxygenases play crucial roles in the biosynthesis of signalingcompounds such as abscisic acid, gibberellins, and ethylene and also ofsecondary metabolites, notably flavonoids and alkaloids. Surveys ofreactions catalyzed by dioxygenases are provided by several articles andreferences therein (Prescott and John, Annu. Rev. Plant Physiol. PlantMol. Biol., 47: 245-271, 1996; Prescott and Lloyd, Nat. Prod. Rep., 17:367-383, 2000; Turnbull et al., J. Biol. Chem., 279: 1206-1216, 2004;Ozer and Bruick, Nat. Chem. Biol., 3: 144-153, 2007).

Plant dioxygenases fall into two classes: lipoxygenases and2-oxoglutarate-dependent dioxygenases (2-ODDs) that catalyzehydroxylation, epoxidation, and desaturation reactions. Members oflatter frequently catalyze more than one type of reaction in successivesteps in a biosynthetic pathway. Enzymes in 2-ODD group show an absoluterequirement for 2-oxoglutarate as a co-substrate. All 2-ODDS are solubleenzymes that require Fe²⁺ and ascorbate for optimal substrate conversionin vitro. Some enzymes have an absolute requirement for ascorbate, butmany do not. Often the role of ascorbate is undefined and is likely tobe indirect and unrelated to the reaction mechanism.

Sequences of 2-ODDS are characterized by conserved residues mainlyclustered in the carboxy-terminal half of the protein. Three-dimensionalstructures have been published for the microbial 2-ODD, isopenicillin Nsynthase (IPNS; Kreisberg-Zakarin et al., Antonie van Leeuwenhoek, 75:33-39, 1999). Although IPNS shows relatively low sequence identity toplant 2-ODDs, it shares a number of conserved residues/motifs andstructural elements and has been proposed as a model for the structureof plant 2-ODDs. The structure show that the catalytic core of the INPSconsist of a double-stranded β-helix (DSBH) fold containing a HX[DE]dyad (where X is any amino acid) and a conserved carboxy-terminalhistidine which together chelate a single iron atom (Kreisberg-Zakarinet al., Antonie van Leeuwenhoek, 75: 33-39, 1999). The conserved portionof 2-ODD super-family proteins comprises the core DSBH which is arrangedin two sheets in a jelly-roll topology, a comparatively rare structurein enzymes more commonly found in viral capsid proteins.

Alignments to compare primary amino acid sequences of a large group ofnon-heme Fe(II)-dependent dioxygenases, all of which activate molecularoxygen and carry out diverse reactions such as aliphatic hydroxylations,desaturations and cyclizations, were analyze (Kreisberg-Zakarin et al.,Antonie van Leeuwenhoek, 75: 33-39, 1999). Sequence analysis of some 52members of this class of enzymes established that five residues aloneare conserved throughout—Gly41, His212, Asp214, His268 and Arg277,numbering according to S. jumonjinensis IPNS (Borovok et al.,Biochemistry, 35: 1981-1987, 1996). Biochemical analysis revealed thatmutant enzymes in His212, Asp214 and His268 have no activity in vitro(Tan and Sim, J. Biol. Chem., 271: 889-894, 1996; Loke et al., FEMSMicrobiol. Lett., 157: 137-140, 1997), implying that the two conservedhistidines and aspartic acids are essential for IPNS activity. A moreextensive analysis comprising 139 non-redundant non-heme,Fe(II)-dependent dioxygenases revealed that both the two histidines andthe aspartic acid and the glycine are fully conserved (Kreisberg-Zakarinet al., Antonie van Leeuwenhoek, 75: 33-39, 1999). This analysis wasused to define a sequence motif that is common to all the non-hemeFe(II) dependent dioxygenases, His-X-Asp(53-57)X-His, which is presumedto be necessary for binding of the iron in the active site (Borovok etal., Biochemistry, 35: 1981-1987, 1996). No role so far has beenascribed to the Gly41.

Against this background, the present invention describes a method formodifying plant architecture and enhancing plant biomass and/or sucroseyield through the down-regulation of a dioxygenase-encoding gene.

All technical terms employed in this description are in common use inthe fields of biochemistry, molecular biology, immunology andagriculture; hence, they are easily understood by a person skilled inthe art to which the present invention belongs. These technical termscan be found, for instance, in: MOLECULAR CLONING: A LABORATORY MANUAL,3^(rd) ed., vol. 1-3, ed. Sambrook and Russel, Cold Spring HarborLaboratory Press, Cold Spring Harbor, N.Y., 2001; CURRENT PROTOCOLS INMOLECULAR BIOLOGY, ed. Ausubel et al., Greene Publishing Associates andWiley-Interscience, New York, 1988 (with periodic updates); SHORTPROTOCOLS IN MOLECULAR BIOLOGY: A COMPENDIUM OF METHODS FROM CURRENTPROTOCOLS IN MOLECULAR BIOLOGY, 5^(th) ed., vol. 1-2, ed. Ausubel etal., John Wiley & Sons, Inc., 2002; GENOME ANALYSIS: A LABORATORYMANUAL, vol. 1-2, ed. Green et al., Cold Spring Harbor Laboratory Press,Cold Spring Harbor, N.Y., 1997; Harlow and Lane (ANTIBODIES: ALABORATORY MANUAL, Cold Spring Harbor Laboratory Press, Cold SpringHarbor, N.Y., 1988. Methodology involving plant biology techniques isdescribed herein and is described in detail in treatises such as METHODSIN PLANT MOLECULAR BIOLOGY: A LABORATORY COURSE MANUAL, ed. Maliga etal., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.,1995. Various techniques using PCR are described, e.g., in Innis et al.,PCR PROTOCOLS: A GUIDE TO METHODS AND APPLICATIONS, Academic Press, SanDiego, 1990 and in Dieffenbach and Dveksler, PCR PRIMER: A LABORATORYMANUAL, 2^(nd) ed., Cold Spring Harbor Laboratory Press, Cold SpringHarbor, N.Y., 2003. PCR-primer pairs can be derived from known sequencesby known techniques such as using computer programs intended for thatpurpose, e.g., Primer, Version 0.5, 1991, Whitehead Institute forBiomedical Research, Cambridge, Mass. Methods for chemical synthesis ofnucleic acids are discussed, for example, in Beaucage & Caruthers,Tetra. Letts. 22: 1859-1862 (1981), and Matteucci & Caruthers, J. Am.Chem. Soc. 103: 3185 (1981).

Restriction enzyme digestion, phosphorylation, ligation andtransformation were performed as described in Sambrook et al., MOLECULARCLONING: A LABORATORY MANUAL, 2^(nd) ed. (1989), Cold Spring HarborLaboratory Press, unless otherwise specified. All reagents and materialsused for the growth and maintenance of bacterial cells were obtainedfrom Aldrich Chemicals (Milwaukee, Wis.), DIFCO Laboratories (Detroit,Mich.), Invitrogen (Gaithersburg, Md.), or Sigma Chemical Company (St.Louis, Mo.), unless otherwise specified.

The terms “encoding” and “coding” refer to the process by which apolynucleotide, through the mechanisms of transcription and translation,provides information to a cell from which a series of amino acids can beassembled into a specific polypeptide. Because of the degeneracy of thegenetic code, certain base changes in DNA sequence do not change theamino acid sequence of a protein.

The term “expression” denotes the production of the polypeptide encodedby a polynucleotide. Alternatively or additionally, “expression” denotesthe combination of intracellular processes, including transcription andtranslation, undergone by a coding DNA molecule such as a structuralgene to produce a polypeptide. “Down-regulation” and “suppression” areused synonymously to indicate that the expression of a particular genesequence in a cell or plant has been reduced relative to a control cellor plant.

The phrase “altered expression” in reference to a polynucleotideindicates that the pattern of expression in, e.g., a transgenic plant orplant tissue, is different from the expression pattern in a wild-typeplant of the same species. Thus, the polynucleotide of interest isexpressed in a cell or tissue type other than a cell or tissue type inwhich the sequence is expressed in the wild type plant, or by expressionat a time other than at the time the sequence is expressed in the wildtype plant, or by a response to different inducible agents, such ashormones or environmental signals, or at different expression levels,compared with those found in a wild type plant. The resulting expressionpattern can be transient or stable, constitutive or inducible. Withreference to a polypeptide, “altered expression” further may relate toaltered activity levels resulting either from altered protein levels orfrom interactions of the polypeptides with exogenous or endogenousmodulators, or from interactions with factors or as a result of thechemical modification of the polypeptides.

The terms “exogenous nucleic acid” and “heterologous nucleic acid” areused interchangeably and refer to a nucleic acid, DNA or RNA, which hasbeen introduced into a cell (or the cell's ancestor) through the effortsof humans. Such exogenous nucleic acid may be a copy of a sequence whichis naturally found in the cell into which it was introduced, orfragments thereof.

In contrast, the term “endogenous nucleic acid” refers to a nucleicacid, gene, polynucleotide, DNA, RNA, mRNA, or cDNA molecule that ispresent in a plant or organism that is to be genetically engineered. Anendogenous sequence is “native” to, i.e., indigenous to, the plant ororganism that is to be genetically engineered.

The phrase “homologous sequences” refers to polynucleotide orpolypeptide sequences that are similar due to common ancestry andsequence conservation. Homologous sequences may be “orthologous,” ifthey were separated by a speciation event, or “paralogous,” if they wereseparated by a gene duplication event.

The phrase “functional homolog” refers to a polynucleotide orpolypeptide sequences that are similar due to common ancestry andsequence conservation and have identical or similar function at thecatalytic, cellular, or organismal levels.

Dioxygenase Sequences

Dioxygenase-encoding genes have been identified in several plantfamilies, exemplified by Poaceae members such as sugarcane and sorghum.In accordance with the present invention provides,2-oxoglutarate-dependent dioxygenase (2-ODD) sequences can be employed,as described above, to modify plant architecture and to enhance biomassand/or sucrose yield.

In the context of the present invention, “Ss-2ODD1” refers to a plantenzyme for which decreased protein levels and/or activity results inplants with modified architecture and enhanced biomass and/or sucroseyield. In the context of the present invention, “Ss-2ODD1” refers to aplant enzyme whose decreased protein levels and/or suppression ofactivity confers modified plant architecture and increased sucroseand/or biomass, as well as possesses dioxygenase activity having thepotential to catalyze at least one of the following reactions:

(a) activation of molecular oxygen and catalysis of substrateconversions, including hydroxylation, desaturation, cyclization, andepoxidation, with or without 2-oxoglutarate requirement as aco-substrate;(b) oxidation of biomolecules (metabolites and macromolecules) with orwithout an ascorbate requeriment as cofactor;(c) catalysis of oxygen incorporation from O₂ in organic (metabolitesand macromolecules) substrates;(d) biosynthesis or degradation of plant signaling compounds suchabscisic acid, gibberellins and ethylene; and(e) biosynthesis or degradation of secondary metabolites, notablyflavonoids and alkaloids.

The polynucleotides of the invention encode polypeptides characterizedby a high sequence identity to 2-oxoglutarate-dependent dioxygenase(2-ODD) polypeptides. While exemplary 2-ODD sequences are derived fromPoaceae, such as the Saccharum spp. 2-ODD (Ss2-ODD1), functionalhomologs from other plant families can be used to produce plants withmodified plant architecture and at least one of enhanced biomass andincreased sucrose yield. As shown in FIG. 2, 2-ODD sequences have beenidentified in several plant families: Poaceae (e.g., sugarcane andsorghum), Cucurbitaceae (e.g., pumpkin and winter squash), Brassicaceae(e.g., Arabidopsis), Solanaceae (e.g., tobacco and tomato), Leguminosae(e.g., garden pea), and Apocynaceae (e.g., Madagascar periwinkle), interalia. It is expected that plant 2-ODD genes from other plant familiescatalyze the same reactions affected by the Ss2-ODD1 enzyme (SEQ ID NO:2) that illustrative SEQ ID NO: 1 encodes; hence, a reduced expressionof such genes should lead to the phenotypes described above andillustrated by plants described in the examples, infra.

Furthermore, common genetic mechanisms control vegetative architecturewithin the Poaceae family and even across dicot and monocot species. Forexample, see Doust, Ann. Bot. 100: 941-50, 2007, and publications citedtherein. Accordingly, the identification and isolation from differentfamilies of functional homologs that control plant architecture andbiomass accumulation should permit the modification of thesecharacteristics in a wide range of plants, pursuant to the presentinvention.

Additional 2-ODD sequences can be identified and functionally annotatedby sequence comparison. Thus, the skilled person can readily identify afunctionally related Ss2-ODD1 sequence in a suitable database, such asGenBank, using publicly available sequence-analysis programs andparameters. Sequences initially identified as 2-ODD may be characterizedfurther, thereby to identify sequences that comprise specified sequencestrings corresponding to sequence motifs present in families of knowndioxygenases. Alternatively, screening cDNA libraries or genomiclibraries, employing suitable hybridization probes and conditions,should lead to the identification of functionally related Ss2-ODD1sequences. It is appreciated in the field as well that sequences withreduced levels of identity also can be isolated with the aid of(degenerate) oligonucleotides and PCR-based methodology.

Via the techniques described above, therefore, a sequence can beidentified and functionally annotated as belonging to the Ss2-ODD1family. By the same token, “Ss2-ODD1 DNA sequence” in this descriptionrefers to any nucleic acid molecule with a nucleotide sequence capableof hybridizing under stringent or highly stringent conditions with thesequence set forth in SEQ ID NO: 1, and encodes an Ss2-ODD1 enzyme asdefined above. The category denoted by the term also encompassessequences which cross-hybridize with SEQ ID NO: 1, preferably having atleast 40%, preferably at least 60%, especially preferably at least 80%and particularly preferably at least 90%, 91%, 92%, 93%, 94%, 95%, 96%,97%, 98%, 99%, or 99.9% identity with the Ss2-ODD1 nucleotide sequenceshown in SEQ ID NO: 1. The nucleotide sequence of the invention mayencode a protein that is homologous to the predicted gene product setforth in SEQ ID NO: 2.

The phrase “stringent conditions” here connotes parameters with whichthe art is familiar. Single-stranded polynucleotides hybridize when theyassociate based on a variety of well-characterized physicochemicalforces, such as hydrogen bonding, solvent exclusion, and base stacking.The stringency of a hybridization reflects the degree of sequenceidentity of the nucleic acids involved, such that the higher thestringency, the more similar are the two polynucleotide strands.Stringency is influenced by a variety of factors, including temperature,salt concentration and composition, organic and non-organic additives,solvents, etc. present in both the hybridization and wash solutions andincubations (and number).

For hybridization of complementary nucleic acids, which have more than100 complementary residues, on a filter in a Southern or Northern blot,“stringent” hybridization conditions are exemplified by a temperaturethat is about 5° C. to 20° C. lower than the thermal melting point (Tm)for the specific sequence, at a defined ionic strength and pH. The Tm isthe temperature, under defined ionic strength and pH, at which 50% ofthe target sequence hybridizes to a perfectly matched probe. Nucleicacid molecules that hybridize under stringent conditions typically willhybridize to a probe based on either the entire cDNA or selectedportions. More preferably, “stringent conditions” here refers toparameters with which the art is familiar, such as hybridization in3.5×SSC, 1×Denhardt's solution, 25 mM sodium phosphate buffer (pH 7.0),0.5% SDS, and 2 mM EDTA for 18 hours at 65° C., followed by four washesof the filter, at 65° C. for 20 minutes, in 2×SSC and 0.1% SDS, and afinal wash for up to 20 minutes in 0.5×SSC and 0.1% SDS or 0.3×SSC and0.1% SDS for greater stringency, and 0.1×SSC and 0.1% SDS for evengreater stringency. Other conditions may be substituted, as long as thedegree of stringency is equal to that provided herein, using a 0.5×SSCfinal wash. For identification of less closely related homologues washescan be performed at a lower temperature, e.g., 50° C. In general,stringency is increased by raising the wash temperature and/ordecreasing the concentration of SSC.

The invention provides nucleic acid molecules comprising the nucleotidesequence of SEQ ID NO: 1, encoding an amino acid sequence set forth inSEQ ID NO: 2. It is understood that the protein of the inventionencompasses amino acid substitutions, additions, and deletions that donot alter the function of the enzyme. For example, substitutions,deletions and insertions introduced into the inventive sequences arealso embraced by the invention. Such sequence modifications can beengineered into a sequence by site-directed mutagenesis or by othermethods known in the art. Amino acid substitutions are typically ofsingle residues; insertions usually will be on the order of about from 1to 10 amino acid residues; and deletions will range about from 1 to 30residues. In preferred embodiments, deletions or insertions are made inadjacent pairs, e.g., a deletion of two residues or insertion of tworesidues. Substitutions, deletions, insertions or any combinationthereof can be combined to arrive at a sequence. The mutations that aremade in the polynucleotide encoding an ODD1 polypeptide, such as theSs2-ODD1, should not place the sequence out of reading frame and shouldnot create complementary regions that could produce secondary mRNAstructure. Preferably, the polypeptide encoded by the DNA performs thedesired function.

Dioxygenases sequences that are homologous to the listed sequences willtypically share at least about 40% amino acid sequence identity. Moreclosely related dioxygenases amino acid sequences share at least about50%, about 60%, about 65%, about 70%, about 75% or about 80% or about90% or about 95%, 96%, 97%, 98% or even 99.9% amino acid sequenceidentity with the listed sequences. At the nucleotide level, thesequences will typically share at least about 40% nucleotide sequenceidentity, preferably at least about 50%, about 60%, about 70% or about80% sequence identity, and more preferably about 85%, about 90%, about95% or about 97% or more sequence identity to one or more of the listedsequences. The degeneracy of the genetic code enables major variationsin the nucleotide sequence of a polynucleotide while maintaining theamino acid sequence of the encoded protein.

Accordingly, the present invention embraces any nucleic acid, gene,polynucleotide, DNA, RNA, mRNA, or cDNA molecule that is isolated from aplant that encodes a 2-ODD polypeptide and whose suppression modifiesplant architecture and increases plant biomass and/or sucrose yield. TheDNA or RNA may be double-stranded or single-stranded. Single-strandedDNA may be the coding strand, also known as the sense strand, or it maybe the non-coding strand, also called the anti-sense strand.

It will readily be appreciated by those of skill in the art, that any ofa variety of polynucleotide sequences are capable of encoding 2-ODDpolypeptides. Due to the degeneracy of the genetic code, many differentpolynucleotides can encode identical and/or substantially similarpolypeptides in addition to those sequences illustrated in the SequenceListing.

The term “variant” is a nucleotide or amino acid sequence that deviatesfrom the standard, or given, nucleotide or amino acid sequence of aparticular gene or protein. The variant may have “conservative” changes,wherein a substituted amino acid has similar structural or chemicalproperties, e.g., replacement of leucine with isoleucine. A variant mayhave “nonconservative” changes, e.g., replacement of a glycine with atryptophan. Analogous minor variations may also include amino aciddeletions or insertions, or both. Guidance in determining which aminoacid residues may be substituted, inserted, or deleted may be foundusing computer programs well known in the art such as Vector NTI Suite(InforMax, MD) software. “Variant” may also refer to a “shuffled gene,”as described, for example, in U.S. Pat. No. 6,506,603, U.S. Pat. No.6,132,970, U.S. Pat. No. 6,165,793 and U.S. Pat. No. 6,117,679.

Also contemplated are fragments and domains, referred herein asoligonucleotides, which hybridize under at least stringent or highlystringent conditions to a polynucleotide sequence described above. Theoligonucleotides are useful as primers, probes, and the like. Anoligonucleotide suitable for use as probes, primes, sense and antisenseagents is at least about 15 nucleotides in length, more often at leastabout 18 nucleotides, often at least about 21 nucleotides, frequently atleast about 30 nucleotides, or about 40 nucleotides, or more in length.A nucleic acid probe is useful in hybridization protocols, e.g., toidentify additional polypeptide homologues of the invention, includingprotocols for microarray experiments. Primers can be annealed to acomplementary target DNA strand by nucleic acid hybridization to form ahybrid between the primer and the target DNA strand, and then extendedalong the target DNA strand by a DNA polymerase enzyme. Primer pairs canbe used for amplification of a nucleic acid sequence, e.g., by thepolymerase chain reaction (PCR) or other nucleic-acid amplificationmethods.

The term “fragment” or “domain,” with respect to a polypeptide, refersto a subsequence of the polypeptide. In some cases, the fragment ordomain is a subsequence of the polypeptide that performs at least onebiological function of the intact polypeptide in substantially the samemanner, or to a similar extent, as does the intact polypeptide. Forexample, a polypeptide fragment can comprise a recognizable structuralmotif or functional domain such as a DNA binding domain that binds to aDNA promoter region, an activation domain or a domain forprotein-protein interactions. Fragments can vary in size from as few as6 amino acids to the full length of the intact polypeptide, but arepreferably at least about 30 amino acids in length and more preferablyat least about 60 amino acids in length.

As used herein, “Ss2-ODD1 DNA sequence” is understood to mean that theSs2-ODD1 gene includes the sequence set forth in SEQ ID NO: 1, as wellas nucleic acid molecules comprised of variants of SEQ ID NO: 1, withone or more bases deleted, substituted, inserted, or added, whichvariant codes for a polypeptide with at least 40% amino acid sequenceidentity. Accordingly, sequences having “base sequences with one or morebases deleted, substituted, inserted, or added” retain physiologicalactivity even when the encoded amino acid sequence has one or more aminoacids substituted, deleted, inserted, or added. Additionally, multipleforms of Ss2-ODD1 enzyme may exist, which may be due topost-translational modification of the polypeptide or to multiple formsof the Ss2-ODD1 gene. Nucleotide sequences that have such modificationsand that code for a dioxygenase enzyme are included within the scope ofthe present invention.

For example, the poly A tail or 5′- or 3′-end, nontranslation regionsmay be deleted, and bases may be deleted to the extent that amino acidsare deleted. Bases may also be substituted, as long as no frame shiftresults. Bases also may be “added” to the extent that amino acids areadded. It is essential, however, that any such modification does notresult in the loss of dioxygenase enzyme activity. A modified DNA inthis context can be obtained by modifying the DNA base sequences of theinvention so that amino acids at specific sites are substituted,deleted, inserted, or added by site-specific mutagenesis, for example,Zoller & Smith, Nucleic Acid Res. 10: 6487-500, 1982.

Unless otherwise indicated, all nucleotide sequences determined bysequencing a DNA molecule herein were determined using an automated DNAsequencer, such as the Model 373 from Applied Biosystems, Inc.Therefore, as is known in the art for any DNA sequence determined bythis automated approach, any nucleotide sequence determined herein maycontain some errors. Nucleotide sequences determined by automation aretypically at least about 95% identical, more typically at least about96% to at least about 99.9% identical to the actual nucleotide sequenceof the sequenced DNA molecule. The actual sequence can be more preciselydetermined by other approaches including manual DNA sequencing methodswell known in the art. As is also known in the art, a single insertionor deletion in a determined nucleotide sequence compared to the actualsequence will cause a frame shift in translation of the nucleotidesequence such that the predicted amino acid sequence encoded by adetermined nucleotide sequence may be completely different from theamino acid sequence actually encoded by the sequenced DNA molecule,beginning at the point of such an insertion or deletion.

Nucleic Acid Constructs

The present invention includes recombinant constructs comprising one ormore of the nucleic acid sequences herein. The constructs typicallycomprise a vector, such as a plasmid, a cosmid, a phage, a virus (e.g.,a plant virus), a bacterial artificial chromosome (BAC), a yeastartificial chromosome (YAC), or the like, into which a nucleic acidsequence has been inserted, in a forward or reverse orientation. In apreferred embodiment, the construct further comprises regulatorysequences, including, for example, a promoter operably linked to thesequence. Large numbers of suitable vectors and promoters are known andare commercially available.

Recombinant nucleic acid constructs may be made using standardtechniques. For example, a nucleotide sequence for transcription may beobtained by treating a vector containing said sequence with restrictionenzymes to cut out the appropriate segment. The nucleotide sequence fortranscription may also be generated by annealing and ligating syntheticoligonucleotides or by using synthetic oligonucleotides in a polymerasechain reaction (PCR) to give suitable restriction sites at each end. Thenucleotide sequence then is cloned into a vector containing suitableregulatory elements, such as upstream promoter and downstream terminatorsequences.

Typically, plant transformation vectors include one or more cloned plantcoding sequence (genomic or cDNA) under the transcriptional control of5′ and 3′ regulatory sequences and a selectable marker. Such planttransformation vectors typically also contain a promoter (e.g., aregulatory region controlling inducible or constitutive,environmentally- or developmentally-regulated, or cell- ortissue-specific expression), a transcription initiation start site, anRNA processing signal (such as intron splice sites), a transcriptiontermination site, and/or a polyadenylation signal.

Suitable constitutive plant promoters which can be useful for expressingthe ODD1 sequences of the invention include but are not limited to: thecauliflower mosaic virus (CaMV) 35S promoter and the maize polyubiquitinpromoter, which confer constitutive, high-level expression in most planttissues (see, e.g., U.S. Pat. No. 5,510,474; Odell et al., Nature 313:810-812, 1985); the nopaline synthase promoter (An et al., PlantPhysiol. 88: 547-552, 1988); and the octopine synthase promoter (Frommet al., Plant Cell 1: 977-984, 1989); as well as tissue-specific,tissue-preferred, cell type-specific, and inducible promoters. Forexample, in sugarcane, sucrose produced in the leaves accumulates in the“internode,” which refers to the portion of the shoot axis between twonodes, it may be advantageous to use an internode-specific promoter.

The vector may also contain termination sequences, which are positioneddownstream of the nucleic acid molecules of the invention, such thattranscription of mRNA is terminated, and polyA sequences added.Exemplary terminators are the cauliflower mosaic virus (CaMV) 35Sterminator and the nopaline synthase gene (NOS) terminator.

Expression vectors may also contain a selection marker by whichtransformed cells can be identified in culture. The marker may beassociated with the heterologous nucleic acid molecule, i.e., the geneoperably linked to a promoter. As used herein, the term “marker” refersto a gene encoding a trait or a phenotype that permits the selection of,or the screening for, a plant or cell containing the marker. In plants,for example, the marker gene will encode antibiotic or herbicideresistance. This allows for selection of transformed cells from amongcells that are not transformed or transfected.

Examples of suitable selectable markers include adenosine deaminase,dihydrofolate reductase, hygromycin-B-phosphotransferase, thymidinekinase, xanthine-guanine phospho-ribosyltransferase, glyphosate andglufosinate resistance, and amino-glycoside 3′-O-phosphotranserase(kanamycin, neomycin and G418 resistance). These markers may includeresistance to G418, hygromycin, bleomycin, kanamycin, and gentamicin.The construct also may contain the selectable marker gene Bar, whichconfers resistance to herbicidal phosphinothricin analogs like ammoniumgluphosinate. Thompson et al., EMBO J. 6: 2519-23 (1987). Other suitableselection markers are known as well.

Visible markers such as green florescent protein (GFP) may be used.Methods for identifying or selecting transformed plants based on thecontrol of cell division have also been described. See John and VanMellaert, WO 2000/052168, and Fabijansk et al., WO 2001/059086.

Replication sequences, of bacterial or viral origin, may also beincluded to allow the vector to be cloned in a bacterial or phage host.Preferably, a broad host range prokaryotic origin of replication isused. A selectable marker for bacteria may be included to allowselection of bacterial cells bearing the desired construct. Suitableprokaryotic selectable markers also include resistance to antibioticssuch as kanamycin or tetracycline.

Other nucleic acid sequences encoding additional functions may also bepresent in the vector, as is known in the art. For instance, whenAgrobacterium is the host, T-DNA sequences may be included to facilitatethe subsequent transfer to and incorporation into plant chromosomes.

Methods for Altering the Expression of Polynucleotide and PolypeptideSequences

In an aspect of the invention, plant biomass and/or sucrose yield areenhanced by down-regulating the expression of the polynucleotidesequences of the present invention. Various methods forpost-transcriptional gene silencing (PTGS) are well known in the art andmay be used in the present invention.

For example, a reduction or elimination of expression (i.e., a“knock-out”) of the sequences of the present invention in a transgenicplant, e.g., to modify a plant trait, can be obtained by introducing anantisense construct corresponding to the polypeptide of interest as acDNA. For antisense suppression, the polynucleotide sequence orhomologue cDNA is arranged in reverse orientation (with respect to thecoding sequence) relative to the promoter sequence in the expressionvector. The introduced sequence need not be the full-length cDNA orgene, and need not be identical to the cDNA or gene found in the planttype to be transformed. Typically, the antisense sequence may becomplementary to any contiguous sequence of the natural messenger RNA,that is, it may be complementary to the endogenous mRNA sequenceproximal to the 5′-terminus or capping site, downstream from the cappingsite, between the capping site and the initiation codon and may coverall or only a portion of the non-coding region, may bridge thenon-coding and coding region, be complementary to all or part of thecoding region, complementary to the 3′-terminus of the coding region, orcomplementary to the 3′-unstranslated region of the mRNA.

The particular antisense sequence and the length of the antisensesequence will vary, depending, for example, upon the degree ofinhibition desired and the stability of the antisense sequence. Thus,where the introduced sequence is of shorter length, a higher degree ofidentity to the endogenous Ss2-ODD1 sequence will be needed foreffective antisense suppression. While antisense sequences of variouslengths can be utilized, preferably the introduced antisense sequence inthe vector will be from at least 13 to about 15 nucleotides in length,at least 16 to about 21 nucleotides, at least about 20 nucleotides, atleast about 30 nucleotides, at least about 50 nucleotides, at leastabout 75 nucleotides, at least about 100 nucleotides, at least about 125nucleotides, at least about 150 nucleotides, at least about 200nucleotides, or even the entire length of the sequence to bedown-regulated. In addition, the sequences may be extended or shortenedon the 3′ or 5′ ends thereof. Generally available techniques and theinformation provided in this specification can guide the selection ofappropriate Ss2-ODD1-encoding antisense sequences. With reference to SEQID NO: 1 herein, an oligonucleotide of the invention may be a continuousfragment of an Ss2-ODD1 cDNA sequence in antisense orientation, of anylength that is sufficient to achieve the desired effects whentransformed into a recipient plant cell.

The present invention contemplates sense co-suppression of anSs2-ODD1-encoding sequence. Sense polynucleotides employed in carryingout the present invention are of a length sufficient to suppress, whenexpressed in a plant cell, the native expression of the plant Ss2-ODD1protein in that plant cell. Such sense polynucleotides may beessentially an entire genomic or complementary nucleic acid encoding theSs2-ODD1 enzyme, or a fragment thereof, with such fragments typicallybeing at least 15 nucleotides in length. Techniques are generallyavailable for ascertaining the length of sense DNA that results insuppression of the expression of a native gene in a cell.

In an alternate embodiment of the present invention, plant cells aretransformed with a nucleic acid construct containing a polynucleotidesegment encoding an enzymatic RNA molecule (a “ribozyme”), whichenzymatic RNA molecule is directed against (i.e., cleaves) the mRNAtranscript of DNA encoding Ss2-ODD1, as described herein. Ribozymescontain substrate binding domains that bind to accessible regions of thetarget mRNA, and domains that catalyze the cleavage of RNA, preventingtranslation and protein production. The binding domains may compriseantisense sequences complementary to the target mRNA sequence; thecatalytic motif may be a hammerhead motif or other motifs, such as thehairpin motif.

Ribozyme cleavage sites within an RNA target may initially be identifiedby scanning the target molecule for ribozyme cleavage sites (e.g., GUA,GUU or GUC sequences). Once identified, short RNA sequences of 15, 20,30, or more ribonucleotides corresponding to the region of the targetgene containing the cleavage site may be evaluated for predictedstructural features.

The suitability of candidate targets also may be evaluated by testingtheir accessibility to hybridization with complimentaryoligonucleotides, using ribonuclease protection assays as are known inthe art. DNA encoding enzymatic RNA molecules may be produced inaccordance with known techniques. For example, see U.S. Pat. No.4,987,071, U.S. Pat. No. 5,559,021, U.S. Pat. No. 5,589,367, U.S. Pat.No. 5,583,032, U.S. Pat. No. 5,580,967, U.S. Pat. No. 5,595,877, U.S.Pat. No. 5,591,601, and U.S. Pat. No. 5,622,854.

Production of such an enzymatic RNA molecule in a plant cell anddisruption of Ss2-ODD1 protein production reduces protein activity inplant cells, in essentially the same manner as production of anantisense RNA molecule; that is, by disrupting translation of mRNA inthe cell which produces the enzyme. The term “ribozyme” describes anRNA-containing nucleic acid that functions as an enzyme, such as anendoribonuclease, and may be used interchangeably with “enzymatic RNAmolecule.”

The present invention further includes nucleic acids encoding ribozymes,nucleic acids that encode ribozymes and that have been inserted into anexpression vector, host cells containing such vectors, and methodologyemploying ribozymes to decrease Ss2-ODD1 activity in plants.

In another embodiment, the present invention provides double-strandednucleic acid molecules of that mediate RNA interference (RNAi) genesilencing. In an embodiment, the siNA molecules of the invention consistof duplex nucleic acid molecules containing about 15 to about 30 basepairs between oligonucleotides comprising about 15 to about 30 (e.g.,about 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, or 30)nucleotides. In another embodiment, siNA molecules of the inventioncomprise duplex nucleic acid molecules with overhanging ends of about 1to about 32 (e.g., about 1, 2, or 3) nucleotides, for example, about21-nucleotide duplexes with about 19 base pairs and 3′-terminalmononucleotide, dinucleotide, or trinucleotide overhangs. In yet anotherembodiment, siNA molecules of the invention comprise duplex nucleic acidmolecules with blunt ends, where both ends are blunt, or alternatively,where one of the ends is blunt.

A siNA molecule of the present invention may comprise modifiednucleotides while maintaining the ability to mediate RNAi. The modifiednucleotides can be used to improve in vitro or in vivo characteristicssuch as stability, activity, and/or bioavailability. For example, a siNAmolecule of the invention can comprise modified nucleotides as apercentage of the total number of nucleotides present in the siNAmolecule. As such, a siNA molecule of the invention can generallycomprise about 5% to about 100% modified nucleotides (e.g., about 5%,10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%,80%, 85%, 90%, 95% or 100% modified nucleotides). The actual percentageof modified nucleotides present in a given siNA molecule will depend onthe total number of nucleotides present in the siNA. If the siNAmolecule is single stranded, the percent modification can be based uponthe total number of nucleotides present in the single stranded siNAmolecules. Likewise, if the siNA molecule is double stranded, thepercent modification can be based upon the total number of nucleotidespresent in the sense strand, antisense strand, or both the sense andantisense strands.

Plants for Genetic Engineering

The present invention comprehends the genetic manipulation of plants tomodify plant architecture and enhance biomass and/or sucrose yield.

The term “plant” denotes any cellulose-containing plant material thatcan be genetically manipulated, including but not limited todifferentiated or undifferentiated plant cells, protoplasts, wholeplants, plant tissues, or plant organs, or any component of a plant suchas a leaf, stem, root, bud, tuber, fruit, rhizome, or the like. The term“propagule” includes a structure with the capacity to give rise to a newplant, e.g., a seed, a spore, or a part of the vegetative body capableof independent growth if detached from the parent.

“Transgenic plant” refers to a plant or progeny thereof derived from agenetically engineered plant cell or protoplast, wherein the plant DNAcontains an introduced exogenous DNA molecule. Additionally, the“transgenic plant” category includes a transformant in its lineage,e.g., by way of standard introgression or another breeding procedure,such as conventional breeding. In contrast, a plant that is notgenetically manipulated is a control plant and is referred to as a“non-transgenic” plant. Non-transgenic plants can be regenerated fromcultured cells or tissues without prior modification by the introductionof a construct comprising polynucleotide sequence. Additionally,“wild-type plant” refers to a non-transgenic plant whose genome isneither modified by the introduction of a construct comprising thepolynucleotide sequences or fragment thereof of the present inventionnor were regenerated from cultured cells or tissues.

Plants that can be engineered in accordance with the invention includebut are not limited to any higher plants, including gymnosperms,monocotyledonous and dicotyledonous plants. The plants of the presentinvention could include crops, including but not limited to, soybean,wheat, corn, potato, cotton, rice, oilseed rape (including canola),beans, sunflower, alfalfa, sugarcane, turf, barley, rye, millet,sorghum, beet, sugarbeet, cassaya, yam, and sweet potato. The plantsalso may be woody species, such pine, poplar, aspen, willow, andeucalyptus. Also, the plants may be grasses, including but not beinglimited to Saccharum, Erianthus, Miscanthus, Narenga, Sclerostachya,sorghum, maize, teosinte, Tripsacum, millets, teff, switchgrass,napiergrass, rice, wild rice, oat, barley, rye, Brachypodium, ryegrass,fescue, turf grass, or bamboo species. More specifically, plants thatcan be engineered in accordance with the invention include but are notlimited to woody trees, sugarcane and sorghum.

“Sugarcane plant” is understood as meaning a plant of the genusSaccharum, preferably the species Saccharum officinarum, and morepreferably the interspecific hybrid produced by crossing Saccharumofficinarum with Saccharum spontaneum. “Sorghum” refers to any plantthat is a member of the genus Sorghum, and includes “sweet sorghum”varieties having high sugar content.

Methods for Genetic Engineering

The polynucleotides of the invention may be used to produce transgenicplants with modified architecture and enhanced plant biomass and/orsucrose yield.

Transgenic plants (including plant cells, plant explants, or planttissues) incorporating the polynucleotides and/or expressing thepolypeptides of the invention can be produced by a variety of wellestablished techniques as described infra and the selection of the mostappropriate transformation technique may be determined by thepractitioner. Following construction of a vector, most typically anexpression cassette, including a polynucleotide, e.g., a Ss2-ODD1sequence, standard techniques known in the art can be used to introduceand stably integrate the polynucleotide into a plant, a plant cell, aplant explant or a plant tissue of interest. Optionally, the plant cell,explant, or tissue can be regenerated to produce a transgenic plant.

Both monocotyledonous and dicotyledonous angiosperm or gymnosperm plantcells may be transformed. For example, see Klein andFitzpatrick-McElligott, Current Opinion in Biotechnology 4: 583-590,1993; Bechtold et al., C. R. Acad. Sci. Paris 316: 1194-1199, 1993;Koncz and Schell, Mol. Gen. Genet. 204: 383-396, 1986; Paszkowski etal., EMBO J. 3: 2717-2722, 1984; Sagi et al., Plant Cell Rep. 13:262-266, 1994. Agrobacterium species such as A. tumefaciens and A.rhizogenes can be used, for example, in accordance with Nagel et al.,FEMS Microbiol Lett 67: 325-328, 1990. Additionally, plants may betransformed by Rhizobium, Sinorhizobium or Mesorhizobium transformation.Broothaerts et al., Nature 433: 629-633, 2005.

Additional methods for genetically engineering a plant or cell includebut are not limited to electroporation, particle gun bombardment (Kleinet al., Nature 327: 70-73, 1987), calcium phosphate precipitation, andpolyethylene glycol fusion, transfer into germinating pollen grains,direct transformation (Lorz et al., Mol. Gen. Genet. 199: 179-82, 1985),and other methods known to the art.

Suitable protocols are available for Poaceae (corn, sugarcane, sorghum,etc.), Leguminosae (alfalfa, soybean, clover, etc.), Umbelliferae(carrot, celery, parsnip), Cruciferae (cabbage, radish, rapeseed,broccoli, etc.), Curcurbitaceae (melons and cucumber), Gramineae (wheat,corn, rice, barley, millet, etc.), Solanaceae (potato, tomato, tobacco,peppers, etc.), and various other crops. See protocols described inAmmirato et al., Handbook of Plant Cell Culture—Crop Species. MacmillanPubl. Co., N.Y., 1984; Shimamoto et al., Nature 338: 274-276, 1989;Fromm et al., Bio/Technology 8: 833-39, 1990; and Vasil et al.,Bio/Technology 8: 429-34, 1990. Protocols for sugarcane transformationare of particular interest for the present invention. Sugarcane can betransformed by means of the particle gun bombardment, see Bower & Birch,Plant Journal 2: 409-416, 1992; Franks & Birch, Aust. J. Plant Physiol.18: 471-80, 1991; Gallo-Meagher & Irvine, Crop Science 36: 1367-1374,1996; Bower et al., Molecular Breeding 2: 239-249, 1996; Snyman et al.,S. Afr. J. Bot. 62: 151-154, 1996, or by Agrobacterium-mediated genetransfer. See, e.g., Arencibia et al., Transgenic Res. 7: 213-22, 1998.

Methodology for regenerating a transgenic plant from a transformed cellor culture vary according to the plant species but are based on knownmethodology. For example, methods for regenerating transgenic sugarcaneplants are well-known. See, for instance, Weng et al., Pest Manag. Sci.62: 178-87, 2006; Santosa et al., Molecular Biotechnology 28: 113-19,2004; Bower and Birch, Plant Journal 2: 409-416, 1992; and Falco et al.,Plant Cell Reports 19: 1188-194, 2000.

If a selection marker, such as kanamycin resistance, is employed, itmakes it easier to determine which cells have been successfullytransformed. Marker genes may be included within pairs of recombinationsites recognized by specific recombinases such as cre or flp tofacilitate removal of the marker after selection. See U.S. publishedapplication No. 2004/0143874.

Transformed plants are selected that have decreased expression of anendogenous 2-ODD1 gene. For example, an inventive transgenic sugarcaneplant or cell can be distinguished from wild-type sugarcane by the factthat the transgenic plant or cell comprises at least one copy of thenucleic acid molecule set for in SEQ ID NO: 1 stably integrated intotheir genome in addition to copies of such a molecule which occurnaturally in the sugarcane wild-type plants/plant cells. In this case,the transgenic sugarcane plant/cells, for example, can be distinguishedfrom sugarcane wild-type plants/cells because the additional copy orcopies is located at locations in the genome where it does not occur inwild-type plant/cell.

In the context of the present invention, the transgenic plants producedby the methods described supra can be used as a source of a transgene ina conventional breeding program. In general, pollen from a transgenicplant is used to pollinate a non-transgenic plant. The seeds of themother plant can be used to produce a new transgenic plant differentfrom the original transgenic plant produced by the method describedsupra.

Methods for Quantifying Enhanced Biomass and Sucrose Yield

Transgenic plants and cells of the invention are characterized by analtered plant architecture and enhanced biomass and/or enhanced sucroseyield. This is achieved by decreasing or suppressing 2-ODD expression.

The term “trait” refers to a physiological, morphological, biochemical,or physical characteristic of a plant or particular plant material orcell. In some instances, this characteristic is visible to the humaneye, such as seed or plant size, or can be measured by availablebiochemical techniques, such as the protein or sucrose content of plantparts or by the observation of the expression level of genes, e.g., byemploying Northern analysis, RT-PCR, microarray gene expression assaysor reporter gene expression systems, or by agricultural observationssuch as yield or modified architecture.

In this description, the phrase “enhanced biomass” connotes an increasein biomass in one or more parts of a plant, particularly in aboveground(harvestable) parts, increased root biomass or increased biomass of anyother harvestable part, relative to the biomass of the correspondingparts of corresponding non-transgenic plants. “Fiber yield” isunderstood as meaning the total amount of solid, water insolublematerial produced by a plant. For the purposes of this invention, fiberis considered a component of biomass and refers to the bagasse remainingafter sugarcane stalks are crushed to extract their juice. “Enhancedfiber yield” refers to an increase in total fiber yield in transgenicplants relative to non-transgenic plants.

“Sucrose yield” is understood as meaning the total amount of sucroseproduced by a plant. Sucrose yield is quantified by calculating thetotal apparent sucrose, which is defined as the product of juice volumethat is obtained by crushing the stalk, multiplied by the sucroseconcentration in that juice. More preferably, in the context of thepresent invention, sucrose yield means the total amount of sucroseproduced per hectare of a transgenic plantation. The phrase “enhancedsucrose yield” refers to an increase in sucrose content in a transgenicplant in comparison with a non-transgenic one.

“Modified architecture” as defined here includes any change in theappearance or number of any one or more of the leaves, shoots, stems,tillers, inflorescence (for monocotyledonous and dicotyledonous plants),panicles, pollen, ovule, seed, embryo, endosperm, seed coat andaleurone. Additionally or alternatively, “modified architecture” ismanifested by at least one of: an increase in plant height and/orweight, an increase in the number of stalk internodes, increase of thestalk internode diameter and/or increase of the stalk internode length,and more homogeneous internode diameter from the bottom to the top ofthe transgenic plants.

Quantifying Plant Biomass

Enhanced biomass can be determined by measuring more readily discerniblecharacteristics, including but not limited to plant weight and size,stem weight and size, leaf weight and size, root weight and size, andseed number and weight.

A plant having “enhanced biomass” refers to an increase by 2-100%,preferably 5-90%, and more preferably 10-80% of dry and/or fresh weightin a transgenic plant in comparison with a non-transgenic plant.

For the purposes of the present invention, fiber is included in thebiomass. In the case of sugarcane, the fiber content usually ranges from8 to 14% of the fresh weight. As used herein, “fiber” refers to thebagasse or biomass remaining after sugarcane stalks are crushed toextract their juice. Fiber yield is therefore quantified by measuringthe bagasse fresh weight with a high capacity precision balance. Asugarcane mill produces nearly 30% of bagasse out of its total crushing.Many research efforts have attempted to use bagasse as a renewablefeedstock for power generation and for producing bio-based materials.Additionally, bagasse may be used as a primary fuel source because; whenburned in quantity, it produces sufficient heat energy.

A plant having “enhanced fiber yield” refers to an increase in totalfiber yield by 2-70%, preferably by 5-50% and more preferably by 10-40%in comparison with a control plant of the same species or variety.

Quantifying Sucrose Yield

“Sucrose yield” is understood as meaning the total amount of sucroseproduced by a plant. Sucrose yield is quantified by calculating thetotal apparent sucrose, which is defined as the product of juice volumethat is obtained by crushing the stalk, multiplied by the sucroseconcentration in that juice. More preferably, in the context of thepresent invention, sucrose yield means the total amount of sucroseproduced per hectare of a transgenic sugarcane plantation.

A plant having “enhanced sucrose yield” refers to an increase in totalsucrose yield by 2-100%, preferably by 5-90%, and more preferably by10-80% in comparison with a control plant of the same species orvariety.

Evaluating Plant Architecture Modification

In describing a plant of the invention, a plant having “altered plantarchitecture” refers to an alteration in, for example, plant height,weight, and diameter, tiller number, internode number, length andhomogeneity, leaf number, length, width and angle distribution, rootlength, length and weight.

The present invention is further described by reference to the followingexamples, which are illustrative only and not limiting on the invention.

Example 1 Identification and Characterization of Saccharum spp.2-Oxoglutarate-Dependent Dioxygenase (Ss2-ODD1)

Searches with sequences of 2-ODD homologs from rice were performed inthe sugarcane expressed sequence tag (EST) data available at GenBankwith the BLAST algorithm (Altschul et al., J. Mol. Biol. 215: 403-410,19900. Searches with a particular rice 2-ODD homolog (gi 27311281)yielded the identification of two clusters encoding a Saccharum spp.putative 2-ODD homologue. One of these clusters is nearly identical to a2-ODD cDNA clone incomplete at its 3′-end found at GenBank (gi35984354). These clusters were found to correspond to a single cDNAclone, named hereafter Ss2-ODD1 (SEQ ID NO: 1). Ss2-ODD1 contains anopen reading frame (positions 50 to 982) encoding the probablefull-length Ss2-ODD1 polypeptide (SEQ ID NO: 2), as determined bysequence alignment with its most similar plant homologues. Ss2-ODD1encodes a polypeptide of 310 amino acid residues and calculatedmolecular mass of 34,452. Searches in the National Center forBiotechnology Information Conserved Domain Database collection revealeda 2-oxoglutarate-dependent dioxygenase domain (pfam03171) present in thecarboxy-terminal half (residues 170 through 271) of the Ss2-ODD1polypeptide. FIG. 1 illustrates the presence of conserved residues inthis domain, including the iron binding motif His-X-Asp(53-57)X-His thatis common to non-heme Fe(II) dependent dioxygenases (Kreisberg-Zakarinet al., Antonie Van Leeuwenhoek 75: 33-39, 1999). These conservedresidues are presumed to be necessary for iron binding in the activesite (Borovok et al., Biochemistry 35: 1981-1987, 1996).

Example 2 Phylogenetic Analysis

BLAST searches against the National Center for Biotechnology InformationGenBank protein databases with the Ss2-ODD1 sequence yielded somefunctionally characterized 2-ODD proteins and several 2-ODD-likeproteins of unknown function from various higher plant species.Full-length amino acid sequences of members representative of major2-ODD types were aligned with the Clustal algorithm (Sugawara et al.,Nucleic Acids Res. 31: 3497-3500, 2003) using the BLOSUM matrix.Phylogenetic analysis was performed by the Neighbor-Joining (NJ) methodusing MEGA version 3.1 (Kumar et al., Brief Bioinform. 5: 150-163, 2004)with robustness of nodes of the phylogenetic trees assessed bybootstrapping (1,000 resamplings). In the phylogenetic tree thusgenerated (FIG. 2), major functionally distinct 2-ODD groups arerecognizable. Noticeable are a group represented mostly by1-aminocyclopropane-1-carboxylate oxidases, and other group comprisingmostly gibberellic acid-2, -3, and -20 oxidases. In the latter areproteins encoded by genes that affect gibberellin metabolism inArabidopsis thaliana, Oryza sativa and Pisum sativum. Ss2-ODD1 belongsto a distinct group of functionally non-characterized 2-ODDS, along withseveral homologs from Arabidopsis thaliana, Catharanthus roseus,Medicago truncatula, Oryza sativa, Sorghum bicolor, and Zea mays. Theidentification of Ss2-ODD1-related sequences across this range ofspecies suggests broad conservation of this group in themonocotyledoneous and dicotyledoneous Glades.

Example 3 Vector Construction

A 619 by fragment, which spans the nucleotides 58 to 676 of the Ss2-ODD1cDNA (SEQ ID NO: 1), was obtained by RT-PCR using total RNA isolatedfrom immature leaves of the Saccharum hybrid cultivar SP80 1842.Oligonucleotides Ss2-ODD1as Fwd (SEQ ID NO: 3,CGCGGATCCGAACCTGCACCTCCCCGT) and Ss2-ODD1as Rev (SEQ ID NO: 4,CGGACTAGTCAGGCCAGGAGTGCCATC) were designed based on the sequence of anSs2-ODD1 EST (GenBank gi 35984354). BamHI and SpeI sites (underlined)were designed into primers Ss2-ODD1as Fwd and Ss2-ODD1as Rev,respectively. The amplified fragment was cloned into pGEM-T Easy(Promega), verified by sequencing, and excised by digestion with SpeIand BamHI. Digestion products were separated by agarose-gelelectrophoresis, purified, and cloned at the AvrII and BamHI sites ofpUBI (Christensen and Quail, Transgenic Res. 5: 213-218, 1996), placingthe Ss2-ODD1 fragment, in antisense orientation, between thepolyubiquitin gene UBI-1 promoter from maize and the nopaline synthasegene NOS transcriptional terminator from Agrobacterium tumefaciens. Theresulting construct was verified by sequencing. This construct wasdigested with HindIII to release the UBI-1::Ss2-ODD1as::NOS cassete.(FIG. 3). The cassete UBI-1::Bar::NOS (Christensen and Quail, TransgenicRes. 5: 213-218, 1996) cloned in pBLUESCRIPT SK- was released bydigestion with EarI (FIG. 3). Digestion products were separated byagarose-gel electrophoresis, and the fragments corresponding to UBI-1:Ss2-ODD1as::NOS and UBI-1: Bar::NOS cassettes were purified and used forembryogenic sugarcane calli transformation.

Example 4 Sugarcane Transformation

Embryogenic calli cultures were established from apical meristems andprimordial leaves of Saccharum hybrid cultivar RB835486. Eight-week oldcalli were transformed by particle bombardment as described previously(Klein et al., Plant Physiol. 91: 440-444, 1989) with equimolarconcentrations of UBI-1::Bar::NOS and UBI-1::Ss2-ODD1as::NOS expressioncassettes (10 μg DNA/3 mg particle). After bombardment, calli weretransferred to MS medium (Murashige and Skoog, Physiol Plant 15:473-479, 1962) containing 1 mg/L phosphinothricin (PPT) and 1 mg/Lbenzylaminopurine (BAP) to inhibit development of non transgenic tissueand promote shoot regeneration. Two weeks later, calli were transferredto MS medium containing 1 mg/L PPT and 1 mg/L indole-3-butyric acid(IAB) for shoot elongation and to induce root formation. After twoweeks, plantlets were placed into magenta boxes for acclimatization, and2 weeks later shoots (10-15 cm tall) with well-developed roots weretransferred to potting soil and placed in a greenhouse. The regeneratedtransgenic plants were genotyped by PCR analysis for the presence of theselectable marker gene (Bar) and the UBI:Ss2-ODD1as::NOS transgene.Tissue-cultured, non-transgenic controls were obtained by regeneratingplants from embryogenic calli of the Saccharum hybrid cultivar RB835486as described above, except for omitting particle bombardment withexpression cassettes and phosphinothricin selection. Plants werepropagated via stem cuttings.

Example 5 Alteration of Plant Architecture in UBI-1::Ss2-ODD1as::NOSPlants

To assess the effect of reducing Ss2-ODD1 expression in transgenicsugarcane plants, UBI-1::Ss2-ODD1as::NOS independent transgenic eventsand non-transgenic wild type plants of the sugarcane variety RB835486were evaluated in a greenhouse. Plants (12 replicates per event) weregrown in coconut shell fiber substrate in 50-L pots. Plants wereirrigated three times per day (totaling 1.5 L) with a nutrient solution.Up to four tillers per plant were allowed to develop, and the exceedingones were manually removed. Seven months after seedling emergence, theirrigation regime was switched to three cycles of irrigation per daywith tap water (totaling 250 mL) for 14 days to induce maturation. Thetwo most homogeneous tillers from each replicate were selected foranalyses, and their stalks were sectioned below their oldest node. Theeight internodes below the first visible dewlap were identified, thestalks were sectioned at the nodes between the seventh and eighthinternodes, and the apical section of the stalks was discarded alongwith all leaves. Stalk height and weight, and internode number, width,and length were measured. Analysis of variance (ANOVA) and Dunnett'stest for mean comparison for all measurements were performed withMINITAB Release 14.

During the stages of plant growth prior to their completecharacterization, various UBI-1::Ss2-ODD1as::NOS events showedperceptible alterations in their dimensions compared to thenon-transgenic control cultivar RB835486. Measurements at seven monthsafter seedling emergence revealed that events 06, 09, 12, 13, 14, 15,18, and 21 had significantly increased height (FIG. 4) compared to thenon-transgenic control. In events 09, 13, 14, and 15, this is likely dueto a significantly increased internode number (FIG. 5), while in events12, 18, and 21 this is likely a consequence of a significantly increasedmean internode length (FIG. 6). Measurements also revealed thatinternode diameter is significantly increased in events 06 and 21 (FIG.7). As a result of their increased overall dimension, events 06, 09 and21 had significantly enhanced biomass, as illustrated by their stalkfresh weight (FIG. 8). Altogether, reduction of Ss2-ODD1 expressionappears to cause, at various degrees, changes in plant architecture thatlead to increased dimension.

Example 6 Enhanced Sucrose Yield in UBI-1::Ss2-ODD1as::NOS Plants

To assess the effect of reducing Ss2-ODD1 expression in transgenicsugarcane plants, UBI-1::Ss2-ODD1as::NOS independent transgenic eventsand non-transgenic wild type plants of the sugarcane variety RB835486were evaluated in a greenhouse. Plants (12 replicates per event) weregrown in coconut shell fiber substrate in 50-L pots. Plants wereirrigated three times per day (totaling 1.5 L) with a nutrient solution.Up to four tillers per plant were allowed to develop, and the exceedingones were manually removed. Seven months after seedling emergence, theirrigation regime was switched to three cycles of irrigation per daywith tap water (totaling 250 mL) for 14 days to induce maturation. Thetwo most homogeneous tillers from each replicate were selected foranalyses, and their stalks were sectioned below their oldest node. Theeight internodes below the first visible dewlap were identified, thestalks were sectioned at the nodes between the seventh and eighthinternodes, and the apical section of the stalks was discarded alongwith all leaves. For the assessment of appropriate maturation induction,total soluble solids were measured with a handheld Reichert Brix ScaleRefractometer and the ratio between the values obtained for the eightand antepenultimate internodes were calculated. The ratio was found tobe larger than 80% in all cases, which is a positive indication ofmaturation. A three-roller power crusher was used to extract the juicefrom the stalks. The juice was immediately filtered through a stainlesssteel sieve. Volume of juice was measured, which was again filteredthrough a 120-mesh sieve. Estimation of total soluble solids and sucroseconcentration in the juice was immediately performed. Juice totalsoluble solids were measured by refractometry with a Bellingham+StanleyRFM840 Digital Refractometer. Following clarification with a mixture ofcalcium hydroxide, aluminum chloride hexahydrate and Celite, juicesucrose concentration was estimated by measuring the circularbirefringence with a Zeiss Polomat A polarimeter. Sucrose concentrationin the juice was expressed as % POL, which indicates the number of gramsof sucrose per 100 mL of solution. Total apparent sucrose was calculatedas a product of juice volume multiplied by sucrose concentration in it(POL). Analysis of variance (ANOVA) and Dunnett's test for meancomparison were performed with MINITAB Release 14.

Events 06 and 09 had significantly increased juice volume compared tothe non-transgenic control cultivar RB835486 (FIG. 9), while events 13,14, and 21 had significantly increased sucrose concentration in thejuice (FIG. 10). As an estimate for sucrose yields, we calculated thetotal apparent sucrose. This analysis revealed that events 09, 13, 14,20, and 21 had significantly increased sucrose yield (FIG. 11). Thus,reduction of Ss2-ODD1 expression appears to cause changes in juicevolume and its sucrose concentration that lead to an increased sucroseyield.

Example 7 Enhanced Biomass Yield in UBI-1::Ss2-ODD1as::NOS Plants

To assess the effect of reducing Ss2-ODD1 expression in transgenicsugarcane plants, UBI-1::Ss2-ODD1as::NOS independent transgenic eventsand non-transgenic wild type plants of the sugarcane variety RB835486were evaluated in a greenhouse. Plants (12 replicates per event) weregrown in coconut shell fiber substrate in 50-L pots. Plants wereirrigated three times per day (totaling 1.5 L) with a nutrient solution.Up to four tillers per plant were allowed to develop, and the exceedingones were manually removed. Seven months after seedling emergence, theirrigation regime was switched to three cycles of irrigation per daywith tap water (totaling 250 mL) for 14 days to induce maturation. Thetwo most homogeneous tillers from each replicate were selected foranalyses, and their stalks were sectioned below their oldest node. Theeight internodes below the first visible dewlap were identified, thestalks were sectioned at the nodes between the seventh and eighthinternodes, and the apical section of the stalks was discarded alongwith all leaves. A three-roller power crusher was used to extract thejuice from the stalks. Following stalk crushing for juice extraction,the bagasse fresh weight was measured with a high capacity precisionbalance. Analysis of variance (ANOVA) and Dunnett's test for meancomparison were performed with MINITAB Release 14.

This analysis revealed that events 9 and 21 had significantly increasedamounts of bagasse fresh weight compared to the non-transgenic control(FIG. 12), indicating that these events have increased biomass yield.

Example 8 Expression of Ss2-ODD1 Transcripts in Sugarcane Organs

To determine the spatial and temporal abundance of Ss2-ODD1 transcripts,we performed quantitative reverse transcription-polymerase chainreaction (qRT-PCR) using RNA isolated from different organs of wild-typesugarcane plants (cultivar RB835486). Blade of the youngest leaf, shootapex, blade of leaf +4, sheath of leaf +4, internode +4, blade of theoldest green leaf, sheath of the oldest green leaf, internode connectedto the oldest green leaf, antepenultimate internode (from apex to base),and roots were harvested from 8-month old, greenhouse grown plants. Leaf+4 is defined as the fourth youngest leaf with a clearly visible dewlapat the blade joint. Whole leaves and roots were harvested from 30-cmtall seedlings of the same cultivar. Three independent 8 month-oldplants and three pools comprising three seedlings each were used in thisanalysis. Liquid N₂-frozen tissue was ground to powder with mortar andpestle, and total RNA was isolated with the Trizol reagent (Invitrogen)according to the manufacturer's instruction. Total RNA was treated withDNaseI (Promega), and cDNA first strand was synthesized with SuperScriptII Reverse Transcriptase (Invitrogen) using 2 μg of total RNA. One tenthof the cDNA was used in combination with gene specific primers at 500 nMconcentration and SYBR Green PCR Master Mix (Applied Biosystems). PCRwas performed on an ABI Prism 7000 Sequence Detection System (AppliedBiosystems). For amplification of Ss2-ODD1 transcripts, oligonucleotideprimers Ss2-ODD1 Fwd (SEQ ID NO: 5, CAGTTGGTAAAGAGCGGTATTCGGTGGC) andSs2-ODD1 Rev (SEQ ID NO: 6, CTTGATAGGTGGAAACCTTGGTGGACATGC), whichanneal at the 3′ end of Ss2-ODD1 coding sequence (base pair 770 to 880)were used. Actin (SsACT; GenBank gi 53759188), used as a reference gene,was amplified with oligonucleotide primers SsACT Fwd (SEQ ID NO: 7,AAGCAGCATGAAGATCAAGGTCGTTGCAC) and SsACT Rev (SEQ ID NO: 8,CTGTGAACAATTGCCGGGCCAGACTC), which anneal at the 3′ end of SsACT codingsequence (base pair 972 to 1121). Amplification was performed at 50° C.for 2 min, 95° C. for 10 min, and 45 cycles at 95° C. for 15 sec and 60°C. for 1 min. The specificity of the amplification reaction wasevaluated by the analysis of the dissociation curves. The ratio betweenthe amounts of the Ss2-ODD1 and SsACT amplified products was calculatedusing the 2^(ΔΔCt) method (Livak and Schmittgen, Methods 25: 402-408,2001). The normalized expression level for each replicate was calculatedas L=2^(−ΔCt) and ΔCT=CT,Ss2-ODD1−CT,SsACT. Ss2-ODD1 transcript levelsrelative to those of SsACT were calculated as the average of valuesobtained from three independent samples used as biological replicatesfor each organ. Results from this analysis are shown in FIG. 13.

Ss2-ODD1 transcripts were detected in all organs analyzed and, inagreement with its low frequency in ESTs libraries, appeared to be muchless abundant than SsACT transcripts, suggesting a low expression level.Ss2-ODD1 transcripts were most abundant in leaf blades of 8 month-oldplants. The highest expression level was found in the blade of theoldest green leaf, followed by blades of leaf +4 and youngest leaf.Seedling whole leaf showed an intermediate expression level. Lowertranscript levels were found in leaf sheath, root, internode, and shootapex of 8 month-old plants, and the expression was the lowest inseedling root. Although the overall expression pattern indicates thatSs2-ODD1 shows a rather ubiquitous expression, it suggests a functionfor Ss2-ODD1 in actively photosynthesizing leaves.

Example 9 Purification of Ss2-ODD1 Recombinant Protein and Generation ofPolyclonal Ss2-ODD1

Expression of the UBI-1::Ss2-ODD1as::NOS transgene-derived antisensetranscripts were aimed at decreasing Ss2-ODD1 protein abundance. Wesought to produce polyclonal antibodies against recombinant Ss2-ODD1protein for its immunodetection in UBI-1::Ss2-ODD1as::NOS events andnon-transgenic controls to verify whether transgene-derived antisensetranscripts decreased Ss2-ODD1 protein abundance.

The full-length Ss2-ODD1 coding sequence was amplified from cDNAprepared from sugarcane (Saccharum hybrid cultivar RB835486) leaves withHiFi Taq DNA polymerase (Invitrogen) with the Ss2-ODD1 CDS Fwd primer(SEQ ID NO: 9, AGCATGGCAGGCAACCTGCACCTCCCCGTG) and the Ss2-ODD1 CDS Revprimer (SEQ ID NO: 10, CTTATTTGTATGTCGAATTTATTCGCCCAACTACGTATTCCCCAC).The resulting 936-bp amplified fragment was cloned into pET SUMO(Invitrogen) according to the manufacturer's instructions, and itsnucleotide sequence was verified by sequencing. The resulting construct,pET SUMO-Ss2-ODD1, encodes a fusion protein consisting of ahexahistidine-tagged, small ubiquitin modifier (SUMO) polypeptide fusedat the amino terminus of Ss2-ODD1 (SUMO-Ss2-ODD1). A serine codon wasadded, prior the Ss2-ODD1 translation start methionine codon, via theforward oligonucleotide primer to facilitate the removal of SUMO bydigestion with SUMO protease (Invitrogen). pET SUMO-Ss2-ODD1 wastransformed into Escherichia coli CY(DE3) pLysS strain (Farah andReinach, Biochemistry 38: 10543-10551, 1999) and expression ofSUMO-Ss2-ODD1 fusion protein was attained by induction of cell culturesat O.D.₆₀₀˜0.5 with 1 mM isopropyl-β-D-thiogalactopyranoside at 37° C.for 3 hr. Cells were collected by centrifugation and lysed in PBS pH 7.2supplemented with 0.2 mg/mL lysozyme for 30 min on ice, followed bysonication. Lysates were cleared by centrifugation at 15,000 g for 15min. Ten mM imidazole was added to the supernatant and the SUMO-Ss2-ODD1fusion protein was bound to Ni⁺² on a 1-mL HiTrap HP column (Amersham).After extensive washing with 10 mM imidazole on phosphate buffer saline(PBS) pH 7.2, the SUMO-Ss2-ODD1 fusion protein was eluted with a 10-500mM imidazole gradient on PBS pH 7.2. Native Ss2-ODD1 protein wasobtained by cleavage of affinity-purified SUMO-Ss2-ODD1 with SUMOprotease (Invitrogen) and further purified following the manufacturer'sinstructions, except for carrying out the digestion by SUMO protease at25° C. for 4 h.

Native Ss2-ODD1 (150 μg) was injected in rabbits with Freund's completeadjuvant. Three boost injections were made with 150 μg of Ss2-ODD1 andFreund's incomplete adjuvant. Antibodies were affinity-purified fromcrude sera as described by Harlow and Lane (ANTIBODIES: A LABORATORYMANUAL, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.,1988). An IgG-enriched fraction was obtained from crude antisera byprecipitation at 50% ammonium sulfate saturation. The resulting pelletwas solubilized in PBS pH 7.2, and dialyzed. This fraction was depletedof non-Ss2-ODD1 antibodies by continuous circulation on a 1-mL HiTrap HPcolumn (Amersham) with bound hexahistidine-tagged SUMO-CAT(chloramphenicol acetyl transferase) fusion protein expressed from theconstruct pET SUMO-CAT (Invitrogen) overnight at 4° C. Subsequently, theflowthrough fraction was continuously circulated on a 1-mL HiTrapNHS-activated HP column (GE Healthcare Bio-Sciences AB) with covalentlylinked SUMO-Ss2-ODD1 fusion protein overnight at 4° C. Theantibody-adsorbed column was washed extensively with PBS pH 7.2, andantibodies were eluted with 100 mM NaCl, 100 mM glycine, pH 2.4.Collected fractions were immediately neutralized with 0.1 volumes of 2 MTris-HCl pH 8.0; those containing the bulk of IgG were pooled andconcentrated with Centricon-10 spin cartridges (Millipore), followed byextensive buffer exchange with PBS pH 7.2.

Example 10 Ss2-ODD1 Protein Levels in UBI-1::Ss2-ODD1as::NOS Events andNon-Transgenic Controls

Using affinity-purified polyclonal antibodies raised againstrecombinant, native Ss2-ODD1, we performed immunoblot analysis ofSs2-ODD1 in organs of UBI-1::Ss2-ODD1as::NOS events and non-transgeniccontrol plants to verify whether transgene-derived antisense transcriptsdecreased Ss2-ODD1 protein abundance. For each transgenic event orwild-type control, blades of leaf +4 were harvested from 8-month old,greenhouse grown plants. Leaf +4 is defined as the fourth youngest leafwith a clearly visible dewlap at the blade joint.

Harvested plant material was immediately frozen in liquid N₂, stored at−80° C. for subsequent processing, was homogenized into a fine powder inliquid N₂, and transferred to conical microcentrifuge tubes. Threevolumes of ice-cold extraction buffer (100 mM Tris-HCl pH 6.8, 5 mMEDTA, 0.1% SDS, 175 mM β-mercaptoethanol, 10% glycerol) supplementedwith Complete EDTA-free Protease Inhibitor Cocktail (Roche DiagnosticsGmbH) was added to the ground tissue and kept under constant agitationfor 20 mM at 4° C. Homogenates were cleared by centrifugation at 15,000g for 15 mM at 4° C. Protein concentration was determined by theBradford assay (Protein Assay kit, Bio-Rad), using BSA as standard.Soluble protein extracts (50 μg) were separated by 12.5% SDS-PAGE, andblotted onto polyvinylidene difluoride membranes (Hybond-P PVDF,Amersham) in a tank transfer system (Mini Trans-Blot Cell, Bio-Rad) at150 Volts×hours in TGM buffer (25 mM Tris, 192 mM glycine, 20%methanol). Membranes were blocked with 9% fat-free milk solids in TBST(20 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.05% Tween-20), and incubated withaffinity-purified antibodies at 1:1,000 dilution in TBST overnight atRT. Membranes were washed with TBST for 10 mM three times and incubatedwith a 1:10,000 dilution of a donkey anti-rabbit IgG conjugated tohorseradish peroxidase (GE Healthcare Bio-Sciences AB) in TBST for 1.5 hat RT. Membranes were subsequently washed three times with TBST, anddeveloped with ECL Plus (GE Healthcare Bio-Sciences AB) followed byexposure to radiographic film (Hyperfilm ECL; GE Healthcare Bio-SciencesAB) for various time intervals.

Utilizing affinity-purified antibodies, Ss2-ODD1 was detected as apolypeptide of approximately 34 kD in extracts prepared from blades ofleaf +4, corresponding in size to recombinant, native Ss2-ODD1 protein(FIG. 14). Blades of leaf +4 from events 9, 14 and 21 had, at differentdegrees, decreased amounts of Ss2-ODD1 protein compared to wild-typecontrol (FIG. 14). Differences observed ranged from partial reduction tonearly complete abolishment of Ss2-ODD1 protein expression. Ss2-ODD1protein was hardly detected in event 14, indicating that expression ofSs2-ODD1 antisense transcripts caused a drastic reduction in Ss2-ODD1protein expression. Events 9 and 21 had Ss2-ODD1 protein levelsintermediate to those observed in event 14 and wild-type control. Event9 apparently had the least reduction of Ss2-ODD1 protein levels amongthe events analyzed.

Reduction in Ss2-ODD1 protein levels in blades of leaf +4 were nothighly correlated with the manifested phenotypes observed in theUBI-1::Ss2-ODD1as::NOS analyzed. Besides being event-dependent, possiblythe extent of reduction in Ss2-ODD1 protein levels varies in differentorgans, and phenotypes are best correlated with changes in Ss2-ODD1abundance in organs other than blades of leaf +4. Also, it is possiblethat changes in Ss2-ODD1 protein levels must be optimally regulated sothat most favorable phenotypic effects are attained.

1. A transgenic plant belonging to a family selected from the groupconsisting of Poaceoe, Cucurbitaceae, Cruciferaceae, Solanaceae,Leguminosae, and Apocynaceae plant family, wherein the plant contains anendogenous Ss2-ODD1 DNA sequence the expression of which is reducedcompared to a wild-type control plant.
 2. The transgenic plant of claim1, wherein said plant belongs to Poaceae family.
 3. The transgenic plantof claim 2, wherein said plant is sugarcane, sorghum, corn, Miscanthus.4. The transgenic plant of claim 1, wherein said endogenous Ss2-ODD1 DNAsequence is reduced by antisense suppression, sense co-suppression, RNAinterference, or enzymatic RNA.
 5. A method for producing sucrose,comprising (a) providing a transgenic plant having suppressed Ss2-ODD1protein levels; and (b) obtaining sucrose from said plant.
 6. The methodof claim 5, wherein said plant is sugarcane or sorghum.
 7. A method forproducing biomass, comprising (a) providing a transgenic plant havingsuppressed Ss2-ODD1 protein levels; and (b) obtaining biomass from saidplant.
 8. The method of claim 7, wherein said plant is sugarcane orsorghum.
 9. A method for enhancing sucrose yield in a plant, comprisingsuppressing Ss2-ODD1 protein levels in said plant.
 10. The method ofclaim 9, wherein said plant is sugarcane or sorghum.
 11. A method forenhancing biomass in a plant, comprising suppressing Ss2-ODD1 proteinlevels in said plant.
 12. The method of claim 11, wherein said plant issugarcane or sorghum.
 13. A nucleic acid construct comprising anSs2-ODD1 sequence.
 14. A transgenic plant or cell comprising the nucleicacid construct of claim 13.